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Abstract Article Info 
Introduction: Nasopharyngeal carcinoma (NPC) is a malignant squamous cell tumor occurring in the 
nasopharyngeal epithelial region where the cuboid epithelium is transformed into squamous cells. One of the 
typical signs of malignancy is uncontrolled cell proliferation. Ki67 is an immunohistochemical (IHC) test to 
assess cell proliferation activity. Increased Ki67 expression were associated with increased mitotic activity in 
cell proliferation. 
Objective: To determine the correlation of Ki67 expression to regional and distant metastases events of 
nasopharyngeal carcinoma at Dr. Mohammad Hoesin Hospital Palembang. 
Methods: This cross-sectional study was conducted on 31 subjects of NPC patients who had been diagnosed in 
Oncology Division of Department of Ear Nose and Throat Head Neck Surgery, then performed 
immunohistochemistry examination of Ki67 in Department of Anatomical Pathology of Dr. Mohammad Hoesin 
Hospital Palembang. The subjects were collected with consecutive sampling from October to December 2017 
and performed other tests for staging such as computer tomography, chest x-ray and abdominal ultrasound. 
Results: In the Ki67 level correlation analysis of the incidence of metastasis in nasopharyngeal carcinoma, the 
correlation coefficient was 0.98 with very strong correlation strength but the positive correlation was not 
statistically significant (p=0.599). However, in Ki67 level correlation analysis of histopathology result of 
nasopharyngeal carcinoma was found correlation coefficient of 0.385 and positive correlation which was 
statistically significant (p=0.032). 
Conclusion: Ki67 levels of metastatic occurrence in nasopharyngeal carcinoma have no statistically significant 
correlation. However, Ki67 level on histopathological results of nasopharyngeal carcinoma and Ki67 
immunoreactivity with primary tumor has a statistically significant correlation. 
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Nasopharyngeal carcinoma (NPC) is a squamous cell malignant tumor 
that occurs in the border region of the nasopharyngeal epithelium where the 
cuboid epithelium changes into squamous epithelium. One typical sign of 
malignancy is uncontrolled cell proliferation. This is due to gene mutations 
that change the cellular metabolic system of tumor cells. Ki67 is one of an 
immunohistochemical examination (IHK) to assess cell proliferation 
activity. Ki67 protein is a kind of protein that located in the nucleus, useful 
for identification of cell proliferation. Ki67 is known as in indicator of 
mitosis, expressed in all phases of the cell cycle except the G0 phase. 
Increased expression of Ki67 is associated with increased of mitotic activity 
in cell proliferation [1-5]. 
NPC is included in top five malignant tumors with the highest 
frequency in Indonesia and in the head and neck department this was ranks 
first. NPC is ranked fourth after cervical cancer, breast cancer and skin 
cancer. The incident of NPC in Indonesia is around 6.3 per 100,000 
population or around 12,000 new cases each year. At the Dr. Mohammad 
Hoesin Hospital Palembang from January 2013 until July 2017, there were 
284 cases of nasopharyngeal carcinoma [6-10]. 
A study by Zhang et al. who sought for the association between Ki67 
and nm23 expression with the clinicopathology of NPC patients in 
relation to the prognosis. In this study Ki67 expression was higher while 
nm23 was lower in the NPC group (p<0.01). Ki67 and nm23 expressions 
have correlation to disease course, clinical stage, and NPC metastasis. A 
study of Ozel et al. examined that the correlation between histological 
types and p53 and Ki67 expression in the NPC case with the result that 
there was a Ki67 expression that has directly correlation to the high 
expression of p53 [11-13]. 
Hu et al. detected cyclinD1 and Ki67 expression in NPC against its 
correlation with biological characteristic and prognosis. Patients with low 
cyclinD1 expression and high Ki67 expression have higher radio-
sensitivity and have better prognosis. Ma et al., have analyzed the 
prognostic role of p53 oncoprotein, Ki67 antigen, tumor angiogenesis 
(Microvessel density-MVD), epidermal growth factor (EGFR) and HER2 
receptor protein expression in Chinese population with undifferentiated 
NPC. The result was EGFR expression has a poor correlation with overall 
survival (OS) and disease-free survival (DFS) (p=0.0001 dan p0,01) and 
has a shorter time to progressive (TTP) (p=0.0001). There is no 
relationship between Ki67 and MVD with OS, DFS, TTP, and lymph node 
status. A study on correlation of Ki67 expression on regional and distant 
metastatic event in NPC has never been done before [14, 15]. The purpose 
of this study was to determine the correlation of Ki67 expression on 
regional and distant metastatic events in NPC. 
2. MATERIAL AND METHODS 
This study was an observational analytic study with a cross-sectional 
design. Sample of this study were all patients with nasopharyngeal 
carcinoma in the ORL-HNS clinic in Dr. Mohammad Hoesin Hospital 
Palembang who met included in inclusion criteria from October 2017 until 
November 2017 that taken by consecutive sampling. 
The inclusion criteria included patients with diagnosed of NPC who had 
complete medical record and documented detailed and accurately 
(interpretation of nasopharyngeal biopsy sourced from the anatomical 
pathology installation of dr. Mohammad Hoesin Hospital Palembang, 
computer tomography, chest X-ray and USG of the abdomen) and then 
determining the stage of nasopharyngeal carcinoma accordance with the 
AJCC 2010, while the sample of this study was excluded if the paraffin 
block was damaged so that IHK examination could not be performed to 
assess the level expression of Ki67.   
The data of this study was collected into a study form that was prepared 
and then reported in tables and graphs. The collected data were statically 







analyzed in immunohistochemistry to assess the percentage of Ki67 
expression in NPC patients. After that the data is processed using SPSS 
statistical data processing program, version 21.0. Univariate analysis was 
carried out on the data of the basic characteristics of research subjects to 
describe the research sample. To analyze the strength of correlation between 
the level of expression of Ki67 and tumor metastasis, a Pearson correlation 
test was performed if the data are normally distributed. If the data are not 
normally distributed or in the data are in categorical form, the Spearman 
correlation test is used. The p value is considered significant if p<0.05 with 
a 95% confidence interval. Chi-square is used to see the relationship of 
confounding variables which in categorical. Data from statistical analysis 
results are reported in tables, graphs and by texture. Data processing and 
results will be assisted with SPSS software for windows version 21.0.  
3. RESULT  
This study was conducted on 31 patients with suspected 
nasopharyngeal carcinoma by anamnesis and physical examination and 
biopsy showed squamous cell carcinoma on nasopharynx. Based on gender 
distribution, 26 participants (83.9%) were male and 5 (16.1%) participants 
were female. The age data of the participants showed an abnormal 
distribution (p=0.045). 
Distribution of participants based on age showed mean age 41.68 and 
median 43.00. This study shows that the youngest participants was 20 years 
old and the oldest participants was 58 years old.  
Table 1. General characteristic (Study participants, n=31) 
Variables     N % ?̅? ± SD Median 
Normalit
y test 
Age (year)   41.68±11.128 43(20-58) P=0.045 
Sex 
        Male 







   
BMI 
   Very thin (<17.0) 
   Thin (17.0-18.5) 
   Normal (18.5-25.0) 
   Fat (25.0-27,0) 



















TOTAL 31 100    
p* distribution normality test results based on the Shapiro-Wilk test; normally distributed if p>0.05 
 
Distribution based on body mass index (BMI) shows a median of 20.4 
with the lowest BMI was 17.9 and the highest was 26.0. BMI participants 
were categorized as being very thin, thin, normal, fat, and very fat. The 
highest distribution of participants was in the normal category of 67.8% (21 
people). Then followed by the fat category for 5 participants (16.1%) and 
the thin category in 16.1% (5 people) 
Characteristics of Ki67 expression of this study can be seen in table 2 
the highest Ki67 labelling index was at 51-75%, with 11 participants 
(35.5%). Then in 26-50% there were 9 participants (29%). Labelling index 
>75% for 8 participants (25.8%). The least labelling index was 5-25% for 3 
participants (9.7%). Immunoreactivity <4 in 5 participants (16.1%) and the 
most immunoreactivity was ≥4 in 26 participants (83.9%). The highest 
intensity of outward appearance was +2 in 15 participants (48.4%) which 
the cytoplasm and membrane were smeared in yellow or dark brown. 
Furthermore, the intensity of outward appearance was +3 in 14 participants 
(45.2%) which the cytoplasm and membrane were smeared in dark yellow 
or dark brown with an equal distribution. Intensity of +1 was found in 2 
participants (6.5%) which the cytoplasm and membrane were smeared with 
a faint yellow color. There is no cell which not smeared in yellow color. 
The characteristic of the incidence of nasopharyngeal carcinomas in 
this study can be seen in table 3. The metastatic score obtained a mean of 
40.10 with a standard deviation of 19.03, medium 52 with a minimum of 1 
and maximum of 56. The most common chief complain from participants 
was a lump in neck in 13 participants (41.9%). Nasal complains such as 
nasal congestion and nosebleeds were felt in 11 participants (35.5%). 
Headaches were felt in 5 participants (16.1%). Double vision was 
complained in 1 participant (3.2%) while the other symptoms of difficulty 
of swallowing were felt in 1 participant (3.2%). The result of 
nasopharyngeal carcinoma biopsy in histopathology found squamous cell 
carcinoma (SCC) nonkeratinized in 3 participants (9.7%) and SCC 
undifferentiated in 28 participants (90.3%). In this study there were no 
comorbidities other than nasopharyngeal carcinomas, such as diabetes 
mellitus, pulmonary tuberculosis, hypertension and immune deficiency 
diseases. In this study there were found Stage IV in 21 participants (67.8%). 
Stage III was found in 8 participants (25.8%). Stage I and stage II amounted 
to the same, were found in 1 participant (3.2%). From this study, based on 
total clinical stage score showed an abnormal distribution which p=0.000. 
The mean is 40.10 and median 52 on total clinical stage score. 
Primary tumor (T) obtained T1 in 1 participant (3.2%) where tumor is 
limited to the nasopharynx. T2 found in 7 participants (22.6%) where the 
tumor extends to the nasopharynx. T3 which the tumor was invading to bone 
structure and/or paranasal sinuses in 12 participants (38.7%). T4 which 
tumor was expanding to intracranial and or involvement of cranial nerves, 
hypopharynx, orbital, or extending to the infratemporal fossa or masticator 
space, was found in 11 participants (35.5%). Metastases in regional lymph 
nodes (N), found the most common was N2 which occurred in bilateral 
lymph nodes metastases, the largest diameter was less than 6 cm, above the 
supraclavicular fossa, in 13 participants (41.9%). Followed by N3 in 12 
participants (38.7%) which lymph node metastases was greater than 6 cm 
and or extending to supraclavicular fossa. The absence of regional lymph 
node metastases was found in 4 participants (12.9%). Unilateral lymph node 
metastases less than 6 cm (N1) were found in 2 participants (6.5%). Distant 
metastases (M1) were found in 9 participants (29%) and 22 participants 
(71%) were found no metastases (M0). 
Table 2. Characteristic expression of KI67 
Variables         Total (N)    Persentage (%) 
Labelling Index Ki67       
5-25%                            3 9.7 
26-50%                             9 29 
51-75%                            11 35.5 
>75% 8 25.8 
Imuno reactifity Ki67      
<4                                        5 16.1 
≥4 26 83.9 
Intensity of smeared    
0 0 0 
+1 2 6.5 
+2                                   15 48.4 
+3 14 45.2 
Total 31 100 
It is known that that the data is not distributed normally. Therefore, the 
correlation test between the level of Ki67 to the incidence of metastases in 
nasopharyngeal carcinoma, was carried out using the Spearman test. 
Correlation of Ki67 level to the incidence of metastases in nasopharyngeal 
carcinoma in Dr. Mohammad Hoesin Hospital Palembang did not have a 
significant correlation. However, the correlation of Ki67 levels with 
histopathological results of nasopharyngeal carcinoma and the correlation 
of Ki67 immunoreactivity to primary tumors in nasopharyngeal carcinoma 
have a significant correlation. 
Table 3. Characteristic of nasopharyngeal events (n=31) 
Variables N  %           ?̅? ± SD  Median 
Metastases score               40.10±19.03 52(1-56) 
Chief complains    Lump in the neck 
                               Nasal complains 
                               Headache 
                               Double vision 












Histophatology      Nonkeratinized SCC 






Comorbidities        (+) 






Stadium                  I 
                               II 
                               III 










T                            T1 
                               T2 
                               T3 










N                            No 
                               N1 
                               N2 










M                           M0 






Total 31 100  
In the correlation analysis level of Ki67 to the occurrence of metastases 
in nasopharyngeal carcinoma obtained a correlation coefficient of 0.98 with 
very strong correlation and the positive correlation which not statistically 
significant (p=0.599). However, the correlation analysis level of KI67 to the 







histopathological results of nasopharyngeal carcinoma obtained a 
correlation coefficient of 0.385 with weak correlation strength and the 
positive correlation which statistically significant (p=0.0.32). 
 
Graphic 1. Correlation between Level of KI67 to NPC metastases 
Table 4. Correlation analysis between the level of KI67 to the result of 
metastases score in nasopharyngeal carcinoma 
        
    Metastases score of nasopharyngeal carcinomas 
    Coefficient Correlation (r)                P 
Level Ki67                                0.98                        0.599 
Table 5. Linear regression analysis of histopathological result in 
nasopharyngeal carcinoma 
        
    Histopathological nasopharyngeal carcinoma 
    B                                  R  Sig 
Level Ki67                  1.22                             0.385          0.032 
Table 6. Multivariate analysis factors associated to metastases of 
nasopharyngeal carcinoma 
Variabel B Sig R 
Body mass index               11.2            0.061       0.340 
Multivariate analysis was performed to control for confounding 
variables, which used numerical data linear regression. Linear regression 
was performed level of Ki67 on metastatic scores in nasopharyngeal 
carcinoma. Metastases was more dominated by body mass index (p=0.61). 
4. DISCUSSION 
This is a cross sectional study that aims to determine the correlation 
between the level of Ki67 and the incidence of metastases in nasopharyngeal 
carcinoma in Dr. Mohammad Hoesin Hospital Palembang. This study was 
conducted at the Oncology Clinic Department of ORL-HNS Dr. Mohammad 
Hoesin Hospital Palembang. This study was conducted from October until 
December 2017. Sampling was done by consecutive sampling. About 31 
patients, who treated with suspected nasopharyngeal carcinoma from 
anamnesis and physical examination, were performed biopsy. If the 
histopathological results of squamous cell carcinoma in nasopharynx, the 
clinical staging and immunohistochemical examination were performed. 
The number of samples that included in the criteria in this study were 31 
participants. Based on sex distribution from this study, 26 participants 
(83.9%) were male and 5 (16.1%) participants were female. Data of the age 
showed an abnormal distribution (p=0.045). Distribution of participants 
based on age obtained mean age 41.68 and median 43.00. In this study 
shows that the youngest participants were 20 years old and the oldest 
participants was 58 years old. Distribution based on body mass index (BMI) 
shows a median of 20.4 with the lowest BMI was 17.9 and the highest was 
26.0. BMI participants were categorized as very thin, thin, normal, fat, and 
very fat. The highest distribution of participants was in the normal category 
of 67.8% (21 participants). Then followed by the fat category in 5 
participants (16.1%) and the thin category in 16.1% (5 participants) 
From the study of Zhang et al (2016), from 59 participants they found 
43 participants were male (72.8%) and 16 participants were female (27.2%), 
with the age between 15 to 80 years old, median 48.4 years old. Study by 
Ozel et al (2004) took samples from 20 paraffin blocks of nasopharyngeal 
carcinoma patients, 5 paraffin blocks were excluded due to damage. Out of 
the 15 paraffin blocks, 2 patients were female, and 13 patients were male. 
Hu et al. (2003) in their study reported 56 patients who participated in the 
study were 41 male and 15 females with the mean age was 49 years old 
(between 21 to 68 years old). In a study by Ma et al (2003), 78 participants 
were included in the study, of which 18 participants were female and 60 
participants were male, with range of age between 22 to 79 years old and 
the median was 48 years old [12-15]. 
The most characteristic distribution of Ki67 expression was 51-75%, in 
11 participants (35%). Then in 26-50% there were 9 participants (29%). 
Labelling index >75% in 8 participants (25.8%). The least is 5-25% 
labelling in 3 participants (9.7%). Immunoreactivity <4 was in 5 participants 
(16.1%) and the most immunoreactivity was ≥4 were in 26 participants 
(83.9%). The highest intensity smeared was +2 in 15 participants (48.4%) 
where the cytoplasm and membrane were smeared in yellow or dark brown. 
Furthermore, the intensity of smeared +3 was in 14 participants (45.2%) 
where the cytoplasm and membrane were smeared in dark yellow or dark 
brown with an equal distribution. Smeared intensity of +1 was found in 2 
participants (6.5%) where the cytoplasm and membrane were smeared with 
a faint yellow color. There are no cells which not smeared in yellow color. 
In a study of Zhang et al, they found that Ki67 was positive expressed 
in 4.35% (1/23) of nasopharyngeal mucosal tissue that experienced 
chronic inflammation and in 71.19% (45/59) of nasopharyngeal cancerous 
tissue. Ma et al. reported the results of their study that the expression of 
Ki67 was found in nasopharyngeal cancer. Low labelling index of 0-30% 
in 18 patients (25%), moderate labelling of 31-60% in 41 patients and 
high labelling index of 61-100% in 13 patients (18%). According to Ozel 
et al. The expression of Ki67 was 11% for undifferentiated 
nasopharyngeal carcinoma, 27% for non-keratinized squamous cell 
carcinoma and 32% for differentiated squamous cell carcinoma. 
According to study Hu et al. Ki67 positive tumor cells from 0-31% 
reported in 40 patients (71.4%) are low proliferated index and in 16 
patients (28.6%) are high proliferated index [12-15]. 
Distribution characteristics of the incidence of nasopharyngeal 
carcinoma in this study showed that the main complain felt by the patients 
was a lump in the neck in 13 participants (41.9%). Nasal complains such as 
nasal congestion and nosebleeds were felt in 11 participants (35.5%). 
Headaches were felt in 5 participants (16.1%). Double vision was 
complained by 1 participant (3.2%) while other symptoms difficulty of 
swallowing was felt in 1 participant (3.2%). The result of histopathological 
biopsy of nasopharyngeal were squamous cell carcinoma (SCC) non-
keratinized in 3 participants (9.7%) and SCC undifferentiated in 28 
participants (90.3%). In this study there were no comorbidities other than 
nasopharyngeal carcinomas such as diabetes mellitus, pulmonary 
tuberculosis, hypertension and immune deficiency disease. Stage IV mostly 
reported in this study, which found in 21 participants (67.8%). Stage III was 
found in 8 participants (25.8%). Stage I and II amounted the same, in 1 
participant (3.2%). From this study, based on total clinical stage showed 
abnormal distribution which p=0.000. The mean was 40.10 and median was 
52 on total clinical stage score. 
Primary tumor (T) obtained T1 in 1 participant (3.2%) which the tumor 
is limited in nasopharynx. T2 in 7 participants (22.6%) which the tumor 
extends to the nasopharynx. T3 which the tumor was invading into bone 
structure and /or paranasal sinuses was found in 12 participants (38.7%). T4 
which the tumor has expansion to intracranial and or involvement of cranial 
nerves, hypopharynx, orbital, or extending to the infratemporal fossa or 
masticator space, was found in 11 participants (35.5%). Metastases to 
regional lymph nodes (N), mostly reported was N2 which occurred bilateral 
lymph nodes metastases, with the size less than 6 cm, above supraclavicular 
fossa, was found in 13 participants (41.9%). Followed by N3 found in 12 
participants (38.7%) which the size of metastases was greater than 6 cm and 
or extending to supraclavicular fossa. The absence of regional lymph nodes 
metastases was found in 4 participants (12.9%). Unilateral lymph nodes 
metastases with the size less than 6 cm (N1) were found in 2 participants 
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(6.5%). Distant metastases (M1) were found in 9 participants (29%) and in 
22 participants (71%) found that there were no metastases (M0). 
The study conducted by Ma et al. reported that primary tumor T1 were 
found in 15 participants (19%), T2 were in 33 participants (42%), T3 were 
in 16 participants (21%) and T4 were in 14 participants (18%). Regional 
lymph node enlargement, N1 were found in 22 participants (28%), N2 were 
in 15 participants (19%), N3 were in 15 participants (19%) whereas there 
were 26 participants (33%) reported without enlargement of lymph node. 
The number of patients experiencing distant metastases was found in 7 
participants (8%). Those who were in stage I and II were 29 patients (37%) 
while stage II and IV were 49 patients (63%). According to the study of Hu 
et al reported histopathologic in 43 patients were poorly differentiated 
squamous cell carcinoma, 5 patients undifferentiated squamous cell 
carcinoma and 1 patient differentiated squamous cell carcinoma. The stage 
was determined based on the TNM classification of the Fuzhou conference 
in China in 1992 and found T1 in 12 patients. T2 in 22 patients, T3 in 18 
patients and T4 in 4 patients. Stage I in 3 patients, stage II in 14 patients, 
stage III in 27 patients, and 12 patients in stage IV [14, 15]. 
Correlation level of Ki67 to the incidence of metastases in 
nasopharyngeal carcinoma in Dr. Mohammad Hoesin Hospital Palembang 
did not have a significant correlation. However, the correlation of Ki67 level 
in histopathological nasopharyngeal carcinoma and immunoreactivity of 
Ki67 in primary tumor in nasopharyngeal carcinoma have a significant 
correlation. Correlation analysis of Ki67 level to the occurrence of 
metastases in nasopharyngeal carcinoma reported the coefficient correlation 
was 0.98 with a very strong correlation and the positive correlation was not 
statistically significant (p=0.5999). However, in the linear regression 
analysis of Ki67 level to the histopathological result of nasopharyngeal 
carcinoma, reported the coefficient correlation was 0.385 and the positive 
correlation was statistically significant (p=0.032). Linear regression was 
performed on the Ki67 level to metastatic scores in nasopharyngeal 
carcinoma. Metastases was dominated by body mass index (p=0.061). 
According to the study of Zhang et al. the level of Ki67 was positive 
correlated to clinical stage and distant metastases. Patients who have a high 
Ki67 levels are found at the advanced stage (stage III/IV, p<0.05). However, 
Ki67 expression was not significantly related to sex, age, cervical lymph 
node metastases and primary tumors. According to the study of Ozel et al., 
reported there was a correlation between histopathological subtypes of p53 
and Ki67 expression in nasopharyngeal carcinoma. Several studies have 
reported a correlation between malignancy with the high level of Ki67 and 
its poor prognosis. However, other studies on prostate cancer and head-neck 
cancer, showed no correlation between Ki67 and its prognosis. According 
to study of Ma et al., there is no correlation between Ki67 and MVD on 
Overall Survival (OS), disease-free survival (DFS), progressive time and 
lymph node status. The study of Hu et al., reported patients with low 
cyclinD1 expression and high Ki67 expression have a higher radio-
sensitivity and better prognosis [12-15]. 
5. CONCLUSION 
The conclusion was that the Ki67 labelling index was found mostly in 
51-75% for 11 participants, followed by the second most was at 26-50% for 
9 participants. The highest immunoreactivity of Ki67 was found ≥4 in 26 
participants. Smeared intensity was mostly found +2 in 15 participants. The 
level of Ki67 to the incidence of metastases in nasopharyngeal carcinoma 
has no statistically significant correlation. The level of Ki67 on 
histopathological results of nasopharyngeal carcinoma has a statistically 
significant correlation. Metastases is more dominated by body mass index 
and has a statistically significant correlation. 
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